शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
ADVENZYMESNSEAdvanced Enzyme Technologies Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Tue, 27 May, 2025 · 18:11 IST

As per email received from National Stock Exchange of India Limited dated May 27, 2025, enclosed Financial Results in a machine-readable and searchable form.

ADVENZYMES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.1%Reaction day
₹307.50
prior close
₹314.85
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+0.3%-0.2% vs market
Pharmaceuticals & Biotechnology peers, median of 150sector · industry level-0.3%+0.5% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.5 pts more than its Pharmaceuticals & Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.4
10m
+0.9
15m
+0.8
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.1+0.3-0.2-0.3+0.5
Next day
+0.6+0.7-0.1+0.2+0.4
2d
-0.5+1.0-1.5-0.2-0.3
3d
-0.6+1.1-1.7-0.4-0.2
4d
-0.8+0.8-1.6-0.7-0.2
5d
+0.1+1.3-1.1-0.6+0.8
1w
-1.4+1.7-3.1-0.4-1.0
15d
+9.9+1.5+8.4-1.2+11.1
1m
+4.7+4.0+0.7-0.3+5.0
2m
+11.2+1.8+9.4-0.3+11.5
3m
+5.7-1.0+6.7-3.6+9.2
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals & Biotechnology peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The company is submitting its financial results to the National Stock Exchange in a machine-readable and searchable (XBRL) format, as requested via NSE's email dated May 27, 2025. This is a procedural, routine compliance filing and does not itself disclose fresh financial numbers. The underlying financial results are being resubmitted in a format mandated by the exchange for easier data processing. No specific revenue, profit, or margin figures are revealed in this announcement.

Likely market impact

No direct impact on shareholders or stock price — this is a standard regulatory filing about the format of result submission rather than new financial information or corporate action.